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October 27, 2013, at the age of 81. He is
survived by his life-long wife and partner
in science, Leonore (Lee), four children,
and four grandchildren. Over his career,
the Herzenbergs mentored over 150
students and fellows, authored over 550
papers, and held numerous patents.
Len was born in New York City; he
graduated from Brooklyn College and
earned his PhD from the California Insti-
tute of Technology. Len and Lee moved
to Paris to do a fellowship with Jacques
Monod; there, Len’s work in bacterial
genetics helped define the LacZ operon
(for whichMonod eventually was awarded
the Nobel Prize). They then moved to the
laboratory of Harry Eagle at the National
Institutes of Health in Bethesda, Mary-
land, where Len developed an interest in
somatic cell genetics; part of his work
was to define the minimal components
of cell culture media needed for cloning
and growing cells. In the late 1950s,
Joshua Lederberg recruited Len to be
part of the nascent Department of
Genetics at Stanford University, and he
held his position there until his death.
Once at Stanford, Len’s scientific inter-
ests followed two paths, one examining
the generation of rare variants (with
mutated gene expression) in somatic cell
genetics and the other in cellular immu-
nology. These paths often crossed, and
frustration with difficulties in both areas
led to the development of the flow cytom-
eter as a tool for biologists. Thus, early in
his career at Stanford, he worked with Lee
on studies of H-2 antigens (now known as
part of the major histocompatibility com-
plex [MHC]) to develop antisera that could
be used to target cells expressing these
target proteins for complement-mediated
depletion and to find variant cells that had
downregulated or lost the antigen. Diffi-
culties with characterizing and isolating
lymphocytes by classical means promp-
ted a search for a new approach, as did
the problem of selecting somatic cell
variants. Around this time, Mack Fulwyler
and Marvin Van Dilla at the Los Alamos
National Laboratories in New Mexico
were developing a machine to count and
separate particles for the quantification
of nuclear fallout, which led Len toconsider the possibility of combining this
approach with fluorescence detection,
then only used for microscopy. Efforts to
develop this instrument at Stanford saw
its fruition in a paper entitled ‘‘Cell sorting:
automated separation of mammalian cells
as a function of intracellular fluorescence’’
in Science in 1969. It was not until 1972
that Len coined the term FACS, for fluo-
rescence-activated cell sorting. His article
in Scientific American disseminated the
technology even more widely in 1976.
Len put FACS (he often wore a tee shirt
to meetings with the phrase ‘‘Just the
FACS’’; apologies to the TV show
Dragnet) to work in pursuit of rare cells
and cellular immunology. For example,
he used FACS to isolate rare fetal cells in
maternal circulation and also to follow B
cells during the course of an immune
response. Much of this work benefited
from the development of monoclonal anti-
bodies, which Len pushed while on
sabbatical in Caesar Millstein’s lab at the
Medical Research Council (MRC) Labora-
tories in Cambridge in 1976. He realized
that a key advance for FACS would be
replacing the then predominant poly-
clonal antisera, typically detected with
fluorescently labeled ‘‘second-step’’ anti-
bodies with reproducible and clean-stain-Immunity 39, Ding directly labeled monoclonal antibody
reagents. Thus, Vernon Oi generated a
series of anti-allotype monoclonals as a
graduate student while visiting the MRC
during this period. Len’s lab also gener-
ated a series of monoclonal antibodies
to MHC proteins and diverse mouse cell-
surface proteins, and these antibodies
became key tools in combination with
FACS. Importantly, Len made the deci-
sion to freely distribute these precious re-
agents, including the cell lines that made
them, to the scientific community.
Following the path of somatic cell ge-
netics, Paula Kavathas as a postdoctoral
fellow in Len’s lab used FACS to isolate
mouse adherent cells expressing CD8
from a pool of cells that had been trans-
fected with a subtracted cDNA library
enriched with CD8 transcripts. This work
enabled cloning of human CD8. Jeff
Dangl, then a graduate student in the
lab, used the anti-allotype monoclonal
antibodies that Vern Oi had made to
isolate rare ‘‘switch variants’’ of a cell
line producing dansyl hapten-binding
monoclonal antibodies, which eventually
enabled critical analysis of the effect of
different Fc segments on the function of
antibodies. The idea of pairing the same
antibody variable domain with differentecember 12, 2013 ª2013 Elsevier Inc. 989
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tion: Len, together with Vernon Oi and
Sherie Morrison, generated the first
chimeric antibodies where the V domain
was from mouse but the C domains
were of human origin. The rationale for
the work was clinical relevance in that
therapeutic use of such chimeric reagents
would minimize immune responses by
patients to the engineered antibody, a
precursor of today’s antibody therapeu-
tics. While a postdoctoral fellow in the
lab, Tom Kipps also used the technique
of FACS selection of switch variants to
demonstrate the key role of antibody iso-
type in mediating depletion of cells during
in vivo treatment by the mechanism of
antibody-dependent cellular cytoxicity,
which had implications for later therapeu-
tic application of monoclonal antibodies.
The development of tools that together
with FACS would advance the technology
was a clear goal that Len pursued. An
important advance came from an inter-
esting collaboration between Vernon Oi,
who was by then doing postdoctoral
work in Lubert Stryer’s lab at Stanford,
and Alexander Glazer, a professor at the
University of California, Berkeley. Stryer’s
interest in the biophysical characteriza-
tion of protein structure by a variety of
techniques, including fluorescence life-
time, brought Oi into contact with Gazer,
an expert on the structure of phycobilipro-
teins, light-harvesting proteins of blue-
green algae. Oi realized that important
features of one of these proteins, phyco-
erythrin, were intense fluorescence
together with a large stokes shift (the dif-
ference in wavelength between protein
light absorption and fluorescence emis-
sion). Together with Oi, Len spearheaded
a project to couple the purified phycoery-
thrin to a monoclonal antibody, enabling
high-quality two-color FACS using a sin-
gle laser and three- to four-color FACS
using two lasers, an important break-
through. The use of phycobiliproteins
and small organic dye-coupled deriva-
tives of these proteins later ushered in
the era of polychromatic flow cytometry.
The generation of a series of rat xeno-
geneic monoclonal antibodies specific to
various mouse cell-surface proteins by
Jeff Ledbetter in Len’s lab was also key
to further advances in B cell biology
from Len’s lab. At about this time, David
Parks, a research associate in Len’s lab,
had brought dual-laser FACS to a state990 Immunity 39, December 12, 2013 ª2013where biologists could use it, and one of
us (R.R.H.) had just joined the lab. The
combination of this instrument andmono-
clonal antibodies labeled with different
fluorescent reporters enabled two-,
three-, and finally four-color analysis and
sorting of B cell populations. Also, at
about this time, a curious overlap was
emerging between B and T cells. Ly-1
(CD5), first considered a marker for T
helper cells but then a pan-T cell glyco-
protein, was shown by Len, Noel Warner,
and Lewis Lanier to be expressed on a
series of mouse B cell lymphomas.
When Kyoko Hayakawa joined Len’s lab,
she set out to find the normal counterpart
of these cells, culminating in the discovery
of the ‘‘Ly-1 B cell.’’ Over the next two
decades, Len’s lab produced a large
body of work showing how distinct these
cells were from ‘‘conventional’’ B cells in
terms of ontogeny, precursor pool, self-
renewal capacity, tissue localization, and
production of autoantibodies, also stimu-
lating a large body of work from many
other labs.
Len always understood the great
amount of information that single cell
analysis could provide. In the mid-1980s,
he pushed to develop a reporter gene sys-
tem that could be used at the single-cell
level. In efforts led by Garry Nolan and
Steve Fiering, the lab defined one of the
first quantitative gene reporter assays in
mammalian cells by using fluorogenic
detection of b-galactosidase expression,
dubbed ‘‘FACS-Gal.’’ This system was
extraordinarily sensitive but, importantly,
could be used to isolate and expand rare
cells on the basis of reporter gene expres-
sion. This technology was used to define
gene regulation of a number of promoter
and enhancer systems, including HIV,
cytokine gene-activation markers, and
the identification of cells transduced to
express an unmutated gene (i.e., gene
therapy for an enzyme deficiency). Bill
Kerr led one of the first ‘‘promoter trap’’
efforts to identify genes expressed under
control of particular B cell signaling
elements. Indeed, this technology was
the predecessor to the now widely used
fluorescent proteins. The early experience
of the lab with single-cell reporter
assays was key to the development of
‘‘enhanced’’ fluorescent GFPs and the
application of multicolor versions of GFP.
The availability of reporter gene assays
to quantify HIV expression became a keyElsevier Inc.segue to one of the last major themes of
the laboratory, the role of redox in the
regulation of gene expression, lympho-
cyte activation, and immune function. On
the basis of a personal letter from Wolf
Droge laying out the hypothesis that
HIV-infected adults are under severe
oxidative stress and that this leads to
immune dysregulation, Len initiated a
major effort to explore this field. Initial ex-
periments confirmed the critical interde-
pendence of inflammatory signaling and
oxidative stress in activating HIV; soon,
the lab developed techniques to measure
this stress in lymphocytes in vivo. Len and
Lee’s relentless push to tie the basic
biology to human health led to a small
exploratory trial testing the impact of
N-acetylcysteine (the major precursor in
glutathione biosynthesis) in HIV-infected
adults. Under Lee’s direction, this re-
search continues actively, further eluci-
dating the role of redox in inflammation
and HIV disease.
The investigations into the role of redox
in HIV disease directly led to a massive
expansion in the multiparameter capabil-
ities of FACS. One of us (M.R.) developed
cytometric assays of intracellular gluta-
thione (GSH) levels in leukocytes; this
assay revealed a selective depletion of
(high-GSH) CD8 cells in HIV-infected
adults. Len and Lee recognized the poten-
tial importance of this finding, given that
HIV pathogenesis had to date been
restricted to the virally infectable CD4+
cells. Through the use of four-color immu-
nophenotyping, we discovered that the
high-GSH cells were in fact naive T cells;
the steady loss of naive CD8+ T cells was
critical to our understanding of the perva-
sive immunopathogenesis of HIV disease.
However, it also spurred us to ask why,
after a decade of immunophenotyping of
HIV-infected adults, the loss of a funda-
mentally important population of cells
was missed. The answer lay in the fact
that identifying such cells required the
use of at least four colors, a technological
luxury at the time. Wondering what other
important changes had been missed,
Len organized a new effort to develop
the software, hardware, and reagents to
do polychromatic flow cytometry. Fifteen
years later, few laboratories think twice
about doing six- to eight-color experi-
ments, and many do 15 or more: the era
of high-content multiparameter single-
cell analysis was born.
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arose from the Herzenberg laboratory
benefited from ‘‘too numerous to
remember’’ late-night discussions of a
wide range of topics at the Herzenberg’s
home by a changing array of lab mem-
bers. The level of mentorship and guid-
ance provided by both Len and Lee
cannot be overstated. They both encour-
aged ‘‘discovery science’’ but also critical
thinking and questioning of data, both
one’s own and others’. Much of this
occurred during one-on-one discussion,
but in addition, weekly lab meetings and
a Herzenberg Immunology Journal Club
provided exposure to a broad array of
topics, stimulating (sometimes heated)
discussion and debate. Importantly, the
lab always included scientists from other
countries, leading to a heady cultural mixat the numerous lab get-togethers. Thus,
Len’s lab was an incubator for a large
cadre of junior scientists who then moved
on to establish independent careers
around the world.
As the father of modern flow cytometry
and with numerous fundamental break-
throughs in cellular immunology, Len
was recognized with numerous awards
and recognitions. He was a member of
the National Academy of Sciences and
was awarded a Special Novartis Prize in
Immunology (2004) and the Kyoto Prize
(2006).
Len leaves behind an enormous legacy
of science and technology. Throughout
his life, he also dedicated much time and
resources to social causes. He was an
ardent supporter of women in science;
he worked tirelessly with Lee to overcomeImmunity 39, Dthe unbalanced hurdles and biases that
women faced in the field. The Herzen-
bergs also supported community efforts
to expose young (especially minority and
disadvantaged) teens to science and
research. Those of us who were fortunate
to be mentored by Len are left to aspire to
the generosity in science and community
that he showed.
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